ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Israel stocks rise as TA 35 gains 0.11% on sector strength

Tel Aviv benchmark advanced modestly on Wednesday, led by gains in biomedical, insurance and communications shares, while energy and tech lagged.

PA
Priya Anand · Equities & Earnings Desk · 29 Aug 2026 · 06:20 · 1 min read
Share
Israel stocks rise as TA 35 gains 0.11% on sector strength

Israel’s blue-chip TA 35 index closed 0.11% higher on Wednesday as gains in biomedical, insurance and communications shares offset declines in energy and technology stocks.

The Tel Aviv Stock Exchange’s TA 35, which tracks the 35 largest listed companies by market cap, rose to 12,620 points, up 14 points from the previous close. Advancing issues outnumbered decliners 261 to 206, with 92 stocks unchanged.

Clal Insurance Enterprises Holdings Ltd led sector gains, climbing 2.13% to 25,860 points, followed by Migdal Insurance’s 2.10% rise to 1,945 points. Biomedical shares also contributed, with the sector among the top performers.

Energy and technology stocks weighed on the index. Enlight Energy fell 2.82% to 23,410 points, Navitas Petroleum’s unit declined 2.45% to 13,160 points, and Next Vision Stabilized Systems dropped 2.21% to 19,930 points.

The Israeli shekel strengthened 0.29% against the dollar to 2.98, while the euro held steady at 3.47. The U.S. Dollar Index futures fell 0.28% to 99.12.

Commodities ended lower. Crude oil for October delivery declined 0.74% to $81.75 per barrel, Brent crude for November delivery fell 0.69% to $86.67 per barrel, and gold for December delivery dropped 0.62% to $4,665.29 per troy ounce.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT